The tolerance effect: its relevance to analgesia produced by physiotherapy interventions

Physical Therapy Reviews

Volumn 2, Issue 4, 1997, Pages 227-237

  Souvlis, Tina ^a   Wright, Anthony ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

ACUPUNCTURE; MANIPULATION INDUCED ANALGESIA; MIDBRAIN PERIAQUEDUCTAL GRAY; NON OPIOID ANALGESIA; OPIOID ANALGESIA; STIMULATION PRODUCED ANALGESIA; STRESS INDUCED ANALGESIA; TENS

Indexed keywords

EID: 0142205803     PISSN: 10833196     EISSN: 1743288X     Source Type: Journal    
DOI: 10.1179/ptr.1997.2.4.227     Document Type: Article

References (96)

1. Portenoy RK. Tolerance to opioid analgesics: clinical aspects. Cancer Surveys 1994; 21: 49–65
2. McQuay HJ. Opioid clinical pharmacology and routes of administration. Br Med Bull 1991; 47: 703–17
3. Twycross RG., Opioids. In: Wall PD & Melzack R, (eds). Textbook of Pain. Third ed. Edinburgh: Churchill Livingstone 1994: 943–62
4. Maitland GD. Vertebral Manipulation. Fifth ed. London: Butterworths 1986
5. Thabe H. Electromyography as tool to document diagnostic findings and therapeutic results associated with somatic dysfunctions in the upper cervical spinal joints and sacroiliac joints. Man Med 1986; 2: 53–8
6. Haldeman S. Manipulation and massage for the relief of back pain. In: Wall PD & Melzack R, (eds). Textbook of Pain. Third ed. Edinburgh: Churchill Livingstone 1994: 1251–62
7. Giovanelli B, Thompson E & Elvey R. Measurement of variations in lumbar zygapophyseal joint intracapsular pressure. A pilot study. Austr J Physio 1985; 31: 115–21
8. Wright A & Vincenzio B. Central mobilisation techniques, sympathetic nervous system effects and their relationship to analgesia. In: Shacklock M, (ed). Moving in on Pain. Adelaide: Butterworth Heinneman 1995: 164–73
9. Wright A. Hypoalgesia post manipulative therapy. Man Ther 1995; 1: 11–6
10. Petersen NP, Vicenzino GT & Wright A. The effects of a cervical mobilisation technique on sympathetic outflow to the upper limb in normal subjects. Physio Theory Pract 1993; 9: 149–00
11. Slater H, Vicenzino B & Wright A. "Sympathetic slump": The effects of a novel manual therapy technique on peripheral sympathetic nervous system function. JiMan Manipulative Ther 1994; 2: 156–62
12. McGuiness J, Vicenzino B, & Wright A. The effects of a postero-anterior cervical mobilisation technique on central nervous system function. Physio Theory Pract 1995
13. Vicenzino B, Collins D, & Wright A., Sudomotor changes induced by neural mobilization techniques in asymptomatic subjects. f Man Manipulative Ther 1994;2: 66–74
14. Vicenzino B, Gutschlag F, Collins D, & Wright A. An investigation of the effects of spinal manual therapy on forequarter pressure and thermal pain thresholds and sympathetic nervous system activity in asymptomatic subjects. In: Shacklock M, (ed). Moving in on Pain. Adelaide: Butterworth Heinneman 1995: 185–93
15. Wang Q, Mao L & Han J. Analgesic electrical stimulation of the hypothalamic arcuate nucleus: tolerance and its cross-tolerance to 2 Hz or 100 Hz electroacupuncture. Brain Res 1990; 518: 40–6
16. Bossut DF & Mayer DJ. Electroacupuncture analgesia in rats: naltrexone antagonism is dependent on previous exposure. Brain Res 1991;549: 47–51
17. Chen X-H & Han J-S. All three types of opioid receptors in the spinal cord are important for 2/15 Hz electroacupuncture. Eur f Pharmacol 1992;211: 203–10
18. Takeshige C, Sato T, Mera T, Hisamitsu T & Fang J. Descending pain inhibitory system involved in acupuncture analgesia. Brain Res Bull 1992; 29: 617–34
19. Laakso EL, Crammond T, Richardson C & Galligan JP. Plasma ACTH and beta-endorphin levels in response to low level laser therapy (LLLT) for myofascial trigger points. Laser Ther 1994; 6: 133–42
20. Woolf CJ & Thompson JW. Stimulation fibre-induced analgesia: transcutaneous electrical nerve stimulation (TENS) and vibration. In: Wall PD, Melzack R, (eds). Textbook of Pain. Third ed. Edinburgh: Churchill Livingstone 1994
21. Somers DL & Clemente FR. The neurophysiological basis of peripheral electrical nerve stimulation for the treatment of causalgia. Phys Ther Rev 1996;1: 1—12
22. Kanjhan R. Opioids and pain. Clin Exp Pharmacol Physiol 1995; 22: 397–403
23. Cross SA. Pathophysiology of pain. Mayo Clin Proc 1994; 69: 375–83
24. Watkins LR, Wiertelak EP, Grisel JE, Silbert LH & Maier SF. Parallel activation of multiple spinal opiate systems appears to mediate 'non-opiate' stress-induced analgesias. Brain Res 1992; 594: 99–108
25. Dickenson AH. Mechanisms of analgesic actions of opiates and opioids. Br Med Bull 1991; 47: 690–702
26. Fields HL & Basbaum AI. Central nervous system mechanisms of pain modulation. In: Wall PD & Melzack R, (eds). Textbook of Pain. Third ed. Edinburgh: Churchill Livingstone 1994: 243–60
27. Mansour A, Fox CA, Akil H & Watson SJ. Opioid- receptor mRNA expression in the rat CNS: anatomical and functional implications. Trends Neurosci 1995; 18: 22–9
28. Jacquet YF. The NMDA receptor: central role in pain inhibition in rat periaqueductal gray. Eur J Pharmacol 1988; 154: 271–6
29. Marek P, Page GG, Ben-Eliyahu S & Liebeskind JC. N- methyl-D-aspartate (NMDA) receptor antagonist MK- 801 blocks non-opioid stress-induced analgesia. I. Comparison of opiate receptor-deficient and opiate receptor-rich strains of mice. Brain Res 1991; 551: 293–6
30. Vaccarino AL, Marek P, Sternberg W & Liebeskind JC. NMDA receptor antagonist MK-801 blocks non-opioid stress-induced analgesia in the formalin test. Pain 1992; 50: 119–23
31. Trujillo KA, Akil H. Inhibition of morphine tolerance and dependence by the NMDA receptor antagonist MK-801. Science 1991; 251: 85–7
32. Stevens CW & Yaksh TL. Time course characteristics of tolerance development to continuously infused antinociceptive agents in rat spinal cord. J Pharmacol Exp Ther 1989;251: 216–23
33. Zabala NA & Gomez MA. Morphine analgesia, tolerance and addiction in the cricket pteronemobius sp. (orthoptera insecta). Pharmacol Biochem Behav 1991;40: 887–91
34. Mayer DJ & Hayes RL. Stimulation-produced analgesia: development of tolerance and cross-tolerance to morphine. Science 1975;188: 941–3
35. Lewis JW, Sherman JE & Liebeskind JC. Opioid and non-opioid stress analgesia: assessment of tolerance and cross-tolerance with morphine. JiNeurosci 19816;1: 358–63
36. Vaccarino AL, Marek P, Kest B, et al. Morphine fails to produce tolerance when administered in the presence of formalin pain in rats. Brain Res 1993; 627: 287–90
37. Kissin I, Brown PT, Robinson CA & Bradley EL, Jr. Acute toleration in morphine analgesia: continuous infusion and single injection in rats. Anesthesiology 1991; 74: 166–71
38. Stevens CW & Yaksh TL. Potency of infused spinal antinociceptive agents is inversely related to magnitude of tolerance after continuous infusion. JiPharmacol Exp Ther 1989;250: 1–8
39. Kissin I, Brown PT & Bradley EL, Jr. Magnitude of acute tolerance to opioids is not related to their potency. Anesthesiology 1991; 75: 813–6
40. Paul D & Phillips AG. Associative factors in tolerance to analgesia produced by electrical stimulation in the rat. Behav Neurosci 1990;104: 207–16
41. Cepeda-Benito A & Tiffany ST. Unsignaled delivery of morphine does not disrupt the development of associative tolerance in rats. Pharmacology, Biochem Behav 1996;54: 575–80
42. Trujillo KA & Akil H. Excitatory amino acids and drugs of abuse: a role for N-methyl-D-aspartate receptors in drug tolerance, sensitisation, and physical dependence. Drug Alcohol Depend 1995;38: 139–54
43. Marek P, Ben-Eliyahu S, Vaccarino AL & Liebeskind JC. Delayed application of MK-801 attenuates the development of morphine tolerance in rats. Brain Res 1991; 558: 163–5
44. Lutfy K, Hurlbut DE & Weber E. Blockade of morphine- induced analgesia and tolerance in mice by MK-801. Brain Res 1993; 616: 83–8
45. Mao J, Price DD & Mayer DJ. Mechanisms of hyperalgesia and morphine tolerance: a current view of their possible interactions. Pain 1995; 62: 259–274
46. Basbaum AI. Insights into the development of opioid tolerance. Pain 1995; 61: 349–52
47. Pasternak GW, Kolesnikov YA & Babey A-M. Perspectives on the N-methyl-D-aspartate/nitric oxide cascade and opioid tolerance. Neuropsychopharmacology 1995; 13: 309–13
48. Mayer DJ, Mao J & Price DD. The development of morphine tolerance and dependence is associated with translocation of protein kinase C. Pain 1995; 61: 365–74
49. Chen L & Huang L-YM. Sustained potentiation of NMDA receptor-mediated glutamate responses through activation of protein kinase C by a mu opioid. Neuron 1991;7: 319–26
50. Menard DP, Rossum DV, Kar S, et al. A calcitonin gene-related peptide receptor antagonist prevents the development of tolerance to spinal morphine analgesia. JiNeurosci 1996; 16: 2342–51
51. Wiertelak EP, Yang H-YT, Heilberger KM, Maier SF & Watkins LR. The nature of conditioned anti-analgesia: spinal cord opiate and anti-opiate neurochemistry. Brain Res 1994; 634: 214–26
52. Bhargava HN, Reddy PL & Gudehithlu KP. Down- regulation of N-methyl-D-aspartate receptors of brain regions and spinal cord of rats treated chronically with morphine. Gen Pharmacol 1995; 26: 131–6
53. Gudehithlu KP & Bhargava HN. Differential binding of [3H]MK-801 to brain regions and spinal cord of mice treated chronically with morphine. Gen Pharmacol 1996;27: 91–4
54. Backonja M-M, Miletic G & Miletic V. The effect of continuous morphine analgesia on chronic thermal hyperalgesia due to sciatic constriction injury in rats. Neurosci Lett 1995; 196: 61–4
55. Mao J, Price DD & Mayer DJ. Thermal hyperalgesia in association with the development of morphine tolerance in rats: roles of excitatory amino acid receptors and protein kinase c. f Neurosci 1994; 14: 2301–12
56. Mao J, Price DD & Mayer DJ. Experimental mononeuropathy reduces the antinociceptive effects of morphine: implications for common intracellular mechanisms involved in morphine tolerance and neuropathic pain. Pain 1995; 61: 335–64
57. Gutstein HB, Trujillo KA & Akil H. Does chronic nociceptive stimulation alter the development of morphine tolerance? Brain Res 1995; 680: 173–9
58. Detweiler DJ, Rohde DS & Basbaum AI. The development of opioid tolerance in the formalin test in the rat. Pain 1995;63: 251–4
59. Stein C, Pflüger M, Yassouridis A. et al. No tolerance to peripheral morphine analgesia in presence of opioid expression in inflamed synovia. J Clin Invest 1996; 98: 793–9
60. Dubner R & Max MB. Painful peripheral neuropathies: mechanisms and treatment. In: Besson J-M, (ed). Serotonin and Pain. La Roque-Gageac: Excerpta Medica 1989
61. Reynolds DV. Surgery in the rat during electrical analgesia induced by focal brain stimulation. Science 1969; 164: 444–5
62. Lewis VA & Gebhart GF. Morphine-induced and stimulation produced analgesias at coincident periaqueductal central gray loci: evaluation of analgesic congruence, tolerance, and cross-tolerance. Exp Neurol 1977;57: 934–55
63. Cannon JT, Prieto GJ, Lee A & Liebeskind JC. Evidence for opioid and non-opioid forms of stimulation produced analgesia in the rat. Brain Res 1982; 243: 315–21
64. Terman GW, Shavit Y, Lewis JW, Cannon JT & Liebeskind JC. Intrinsic mechanisms of pain inhibition: activation by stress. Science 1984;226: 1270–7
65. Nichols DS & Thom BE. Stimulation-produced analgesia and its cross tolerance between dorsal and ventral PAG loci. Pain 1990: 347–52
66. Lutfy K, Sadowski B, Kwon I-S & Weber E. Morphine analgesia and tolerance in mice selectively bred for divergent swim stress-induced analgesia. Eur J Pharmacol 1994;265: 171–4
67. Mayer DJ. Endogenous analgesia systems: neural and behavioral mechanisms. In: Bonica JJ, (ed). Advances in Pain Research and Therapy. New York: Raven Press 1979: 385–410
68. Hosobuchi Y, Adams JE & Linchitz R. Pain relief by electrical stimulation of the central gray matter in human and its reversal by naloxone. Science 1977; 197: 183–6
69. Lovick TA. Interactions between descending pathways from the dorsal and ventrolateral periaqueductal gray matter in rats. In: Depaulis A & Bandler R, (eds). The Midbrain Periaqueductal Gray Matter. New York: Plenum Press 1991
70. Behbehani MM. Functional characteristics of the midbrain periaqueductal gray. Prog Neurobiol 1995; 46: 575–605
71. Morgan MM. Differences in antinociception evoked from dorsal and ventral regions of the caudal periaqueductal gray matter. In: Depaulis A & Bandler R, (eds). The Midbrain Periaqueductal Gray Matter. New York: Plenum Press 1991
72. Fanselow MS. The midbrain periaqueductal gray as a coordinator of action in response to fear and anxiety. In: Depaulis A & Bandler R, (eds). The Midbrain Periaqueductal Gray Matter. New York: Plenum Press 1991: 151–73
73. Bodnar RJ, Kelly DD, Steiner SS & Glusman M. Stress- produced analgesia and morphine-produced analgesia: lack of cross-tolerance. Pharmacol Biochem Behav 1978; 8: 661–6
74. Bodnar RJ, Kelly DD, Spiaggia A, Ehrenberg C & Glusman M. Dose-dependent reductions by naloxone of analgesia induced by cold-water stress. Pharmacol Biochem Behav 1978; 8: 667–72
75. Bodnar RJ, Kelly DD, Thomas LW & Glusman M. Two % saline treatment: failure to alter opiate and cold- water stress analgesia. Physiol Behav 1980;24: 805–6
76. Lewis JW, Chudler EH, Cannon JT & Liebeskind JC. Hypophysectomy differentially affects morphine and stress analgesia. Proc West Pharmacol Soc 1981;24: 323–6
77. Bodnar RJ. Types of stress which induce analgesia. In: Tricklebank MD, Curzon G, (eds). Stress-induced Analgesia. John Wiley & Sons Ltd 1984: 19–32
78. Watkins LR, Faris PL, Komisaruk BR & Mayer DJ. Dorsolateral funiculus and intraspinal pathways mediate vaginal stimulation-induced suppression of nociceptive responding in rats. Brain Res 1984;294: 59–65
79. Lee C & Rodgers RJ. Antinociceptive effects of elevated plus-maze exposure: influence of opiate receptor manipulations. Psychopharmacology 1990;102: 507–13
80. Rodgers RJ & Shepherd JK. Stereospecific inhibition of non-opioid defeat analgesia in male mice by MD72832, a selective 5-HT 1A receptor agonist. Eur J Pharmacol 1990;182: 581–5
81. Hodgson DM & Bond NW. Control of food delivery in food deprived rats mediates analgesia. Behav Brain Res 1991;44: 205–9
82. Panocka I, Marek P & Sadowski B. Tolerance and crosstolerance with morphine in mice selectively bred for high and low stress-induced analgesia. Pharmacol Biochem Behav 1991;40: 283–6
83. Tierney G, Carmody J & Jamieson D. Stress analgesia: the opioid analgesia of long swims suppresses the nonopioid analgesia induced by short swims in mice. Pain 1991;46: 89–95
84. Marek P, Mogil JS, Sternberg WF, Panocka I & Liebeskind JC. N-Methyl-D-aspartic acid (NMDA) receptor antagonist MK801 blocks non-opioid stress- induced analgesia. II. Comparison across three swim- stress paradigms in selectively bred mice. Brain Res 1992;578: 197–203
85. Watkins LR, Wiertelak EP & Maier SF. Delta opiate receptors mediate tail-shock induced antinociception at supraspinal levels. Brain Res 1992;582: 10–21
86. Watkins LR, Wiertelak EP & Maier SF. Kappa opiate receptors mediate tail-shock induced antinociception at spinal levels. Brain Res 1992;582: 1–9
87. Grisel JE, Fleshner M, Watkins LR & Maier SF. Opioid and non-opioid interactions in two forms of stress- induced analgesia. Pharmacol Biochem Behav 1993; 45: 161–72
88. Sadowski B & Panocka I. Cross-tolerance between morphine and swim analgesia in mice selectively bred for high and low stress-induced analgesia. Pharmacol Biochem Behav 1993;45: 527–31
89. Mogil JS, Sternberg WF, Balian H, Liebeskind JC & Sadowski B. Opioid and non-opioid swim stress- induced analgesia: a parametric analysis in mice. Physiol Behav 1996;59: 123–32
90. Sutton LC, Fleshner M, Mazzeo R, Maier SF & Watkins LR. A permissive role of corticosterone in an opioid form of stress-induced analgesia: blockade of opiate analgesia is not due to stress-induced hormone release. Brain Res 1994;663: 19–29
91. Watkins LR & Mayer DJ. Involvement of spinal opioid systems in footshock-induced analgesia: antagonism by naloxone is possible only before induction of analgesia. Brain Res 1982;242: 309–16
92. Kavaliers M & Colwell DD. Sex differences in opioid and non-opioid mediated predator-induced analgesia in mice. Brain Res 1991;568: 173–7
93. Wells P & Lessard E. Movement education and limitation of movement. In: Wall PD & Melzack R, (eds). Textbook of Pain. Third ed. Edinburgh: Churchill Livingstone 1994: 1263–78
94. Terman GW, Penner ER & Liebeskind JC. Stimulation- produced and stress-induced analgesia: cross-tolerance between opioid forms. Brain Res 1985; 360: 374–8
95. Kirchgessner AL, Bodnar RJ & Pasternak GW. Naloxazone and pain-inhibitory systems: evidence for a collateral inhibition model. Pharmacol Biochem Behav 1982; 17: 1175–9
96. Jeong Y, Baik E-J, Nam T-S & Paik K-S. Effects of iontophoretically applied naloxone, picrotoxin and strychnine on dorsal horn neuron activities treated with high frequency conditioning stimulation in cats. Yonsei Med J 1995; 36: 336–47